{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:30:03Z","timestamp":1757705403500},"reference-count":25,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2004,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The human T-cell lymphotropic virus type 1 (HTLV-1) is the causative agent of HTLV-1-associated myelopathy\/tropical spastic paraparesis (HT). Although it is widely believed that virus infection and host immune response are involved in the pathogenic mechanisms, the role of the immune system in the development and\/or maintenance of HT remains unknown. We performed an analysis of the peripheral blood leukocyte phenotype for two different subcohorts of HTLV-1-infected individuals to verify the existence of similar immunological alterations, possible laboratory markers for HT. The leukocyte population balance, the activation status of the T lymphocytes, and the cellular migratory potential of T lymphocytes, monocytes, and neutrophils were evaluated in the peripheral blood of HTLV-1-infected individuals classified as asymptomatic individuals, oligosymptomatic individuals, and individuals with HT. Data analysis demonstrated that a decreased percentage of B cells, resulting in an increased T cell\/B cell ratio and an increase in the CD8<jats:sup>+<\/jats:sup>HLA-DR<jats:sup>+<\/jats:sup>T lymphocytes, exclusively in the HT group could be identified in both subcohorts, suggesting its possible use as a potential immunological marker for HT for use in the laboratory. Moreover, analysis of likelihood ratios showed that if an HTLV-1-infected individual demonstrated B-cell percentages lower than 7.0%, a T cell\/B cell ratio higher than 11, or a percentage of CD8<jats:sup>+<\/jats:sup>HLA-DR<jats:sup>+<\/jats:sup>T lymphocytes higher than 70.0%, this individual would have, respectively, a 12-, 13-, or 22-times-greater chance of belonging to the HT group. Based on these data, we propose that the T cell\/B cell ratios and percentages of circulating B cells and activated CD8<jats:sup>+<\/jats:sup>T lymphocytes in HTLV-1-infected patients are important immunological indicators which could help clinicians monitor HTLV-1 infection and differentiate the HT group from the asymptomatic and oligosymptomatic groups.<\/jats:p>","DOI":"10.1128\/cdli.11.6.1105-1110.2004","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T18:37:49Z","timestamp":1100198269000},"page":"1105-1110","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Establishing Phenotypic Features Associated with Morbidity in Human T-Cell Lymphotropic Virus Type 1 Infection"],"prefix":"10.1128","volume":"11","author":[{"given":"G. E. A.","family":"Brito-Melo","sequence":"first","affiliation":[{"name":"Laborato\u0301rio de Imunologia das Faculdades Federais Integradas de Diamantina (FAFEID)"},{"name":"Laborato\u0301rio de Doenc\u0327a de Chagas, CPqRR-FIOCRUZ\/BH"},{"name":"Departamento de Microbiologia, ICB\/UFMG"},{"name":"Fundac\u0327a\u0303o HEMOMINAS"},{"name":"Hospital Sarah Kubitschek, Belo Horizonte, Minas Gerais, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. G.","family":"Souza","sequence":"additional","affiliation":[{"name":"Laborato\u0301rio de Imunologia das Faculdades Federais Integradas de Diamantina (FAFEID)"},{"name":"Laborato\u0301rio de Doenc\u0327a de Chagas, CPqRR-FIOCRUZ\/BH"},{"name":"Departamento de Microbiologia, ICB\/UFMG"},{"name":"Fundac\u0327a\u0303o HEMOMINAS"},{"name":"Hospital Sarah Kubitschek, Belo Horizonte, Minas Gerais, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. F.","family":"Barbosa-Stancioli","sequence":"additional","affiliation":[{"name":"Laborato\u0301rio de Imunologia das Faculdades Federais Integradas de Diamantina (FAFEID)"},{"name":"Laborato\u0301rio de Doenc\u0327a de Chagas, CPqRR-FIOCRUZ\/BH"},{"name":"Departamento de Microbiologia, ICB\/UFMG"},{"name":"Fundac\u0327a\u0303o HEMOMINAS"},{"name":"Hospital Sarah Kubitschek, Belo Horizonte, Minas Gerais, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. B. F.","family":"Carneiro-Proietti","sequence":"additional","affiliation":[{"name":"Laborato\u0301rio de Imunologia das Faculdades Federais Integradas de Diamantina (FAFEID)"},{"name":"Laborato\u0301rio de Doenc\u0327a de Chagas, CPqRR-FIOCRUZ\/BH"},{"name":"Departamento de Microbiologia, ICB\/UFMG"},{"name":"Fundac\u0327a\u0303o HEMOMINAS"},{"name":"Hospital Sarah Kubitschek, Belo Horizonte, Minas Gerais, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Catalan-Soares","sequence":"additional","affiliation":[{"name":"Laborato\u0301rio de Imunologia das Faculdades Federais Integradas de Diamantina (FAFEID)"},{"name":"Laborato\u0301rio de Doenc\u0327a de Chagas, CPqRR-FIOCRUZ\/BH"},{"name":"Departamento de Microbiologia, ICB\/UFMG"},{"name":"Fundac\u0327a\u0303o HEMOMINAS"},{"name":"Hospital Sarah Kubitschek, Belo Horizonte, Minas Gerais, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. G.","family":"Ribas","sequence":"additional","affiliation":[{"name":"Laborato\u0301rio de Imunologia das Faculdades Federais Integradas de Diamantina (FAFEID)"},{"name":"Laborato\u0301rio de Doenc\u0327a de Chagas, CPqRR-FIOCRUZ\/BH"},{"name":"Departamento de Microbiologia, ICB\/UFMG"},{"name":"Fundac\u0327a\u0303o HEMOMINAS"},{"name":"Hospital Sarah Kubitschek, Belo Horizonte, Minas Gerais, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. W.","family":"Thorum","sequence":"additional","affiliation":[{"name":"Laborato\u0301rio de Imunologia das Faculdades Federais Integradas de Diamantina (FAFEID)"},{"name":"Laborato\u0301rio de Doenc\u0327a de Chagas, CPqRR-FIOCRUZ\/BH"},{"name":"Departamento de Microbiologia, ICB\/UFMG"},{"name":"Fundac\u0327a\u0303o HEMOMINAS"},{"name":"Hospital Sarah Kubitschek, Belo Horizonte, Minas Gerais, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. D. R.","family":"Rocha","sequence":"additional","affiliation":[{"name":"Laborato\u0301rio de Imunologia das Faculdades Federais Integradas de Diamantina (FAFEID)"},{"name":"Laborato\u0301rio de Doenc\u0327a de Chagas, CPqRR-FIOCRUZ\/BH"},{"name":"Departamento de Microbiologia, ICB\/UFMG"},{"name":"Fundac\u0327a\u0303o HEMOMINAS"},{"name":"Hospital Sarah Kubitschek, Belo Horizonte, Minas Gerais, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. A.","family":"Martins-Filho","sequence":"additional","affiliation":[{"name":"Laborato\u0301rio de Imunologia das Faculdades Federais Integradas de Diamantina (FAFEID)"},{"name":"Laborato\u0301rio de Doenc\u0327a de Chagas, CPqRR-FIOCRUZ\/BH"},{"name":"Departamento de Microbiologia, ICB\/UFMG"},{"name":"Fundac\u0327a\u0303o HEMOMINAS"},{"name":"Hospital Sarah Kubitschek, Belo Horizonte, Minas Gerais, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"156","year":"1987","unstructured":"Akizuki, S., O. Nakazato, Y. Higuchi, K. Tanabe, M. Setoguchi, S. Yoshida, S. Yamamoto, S. Sudou, K. Sannomiya, and T. Okajima. 1987. Necropsy findings in HTLV-I associated myelopathy. Lanceti:156-157.","journal-title":"Lancet"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cimm.1999.1580","volume":"198","year":"1999","unstructured":"al-Fahim, A., P. Cabre, L. Kastrukoff, K. Dorovini-Sis, and J. Oger. 1999. Blood mononuclear cells in patients with HTLV-I-associated myelopathy: lymphocytes are highly activated and adhesion to endothelial cells is increased. Cell. Immunol.198:1-10.","journal-title":"Cell. Immunol."},{"key":"e_1_3_2_4_2","first-page":"1765","volume":"2","year":"1999","unstructured":"Bieganowska, K., P. Hollsberg, G. J. Buckle, D. G. Lim, T. F. Greten, J. Schneck, J. D. Altman, S. Jacobson, S. L. Ledis, B. Hanchard, J. Chin, O. Morgan, P. A. Roth, and D. A. Hafler. 1999. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2\/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J. Immunol.2:1765-1771.","journal-title":"J. Immunol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-3083.2002.01087.x","volume":"55","year":"2002","unstructured":"Brito-Melo, G. E. A., O. A. Martins-Filho, A. B. F. Carneiro-Proietti, B. Catalan-Soares, J. G. Ribas, G. W. Thorum, E. F. Barbosa-Stancioli, and Grupo Interdisciplinar de Pesquisas em HTLV. 2002. Phenotypic study of peripheral blood leucocytes in HTLV-I-infected individuals from Minas Gerais, Brazil. Scand. J. Immunol.55:621-628.","journal-title":"Scand. J. Immunol."},{"key":"e_1_3_2_6_2","first-page":"273","volume":"155","year":"1999","unstructured":"Cabre, P., A. al-Fahim, and J. Oger. 1999. Enhanced adherence of endothelial cells to blood mononuclear cells in HAM\/TSP. Rev. Neurol.155:273-279.","journal-title":"Rev. Neurol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1590\/S0037-86822002000500013","volume":"35","year":"2002","unstructured":"Carneiro-Proietti, A. B. F., J. G. Ribas, B. Catalan-Soares, M. L. Martins, G. E. A. Brito-Melo, O. A. Martins-Filho, S. R. Pinheiro, A. Q. C. Ara\u00fajo, B. Galv\u00e3o-Castro, M. S. Pombo de Oliveira, A. C. Guedes, and F. A. Proietti. 2002. Infection and disease caused by human T cell lymphotropic viruses type I and II in Brazil. Rev. Soc. Bras. Med. Trop.35:499-508.","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"e_1_3_2_8_2","first-page":"21","volume":"39","year":"1999","unstructured":"Fujihara, K. 1999. Pathogenetic significance of HTLV-I infection and immune surveillance in HAM. Rinsho Shinkeigaku39:21-23.","journal-title":"Rinsho Shinkeigaku"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2249.2000.01211.x","volume":"120","year":"2000","unstructured":"Furukawa, Y., C. R. Bangham, G. P. Taylor, J. N. Weber, and M. Osame. 2000. Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Clin. Exp. Immunol.120:307-316.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_10_2","first-page":"407","year":"1985","unstructured":"Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. De Th\u00e9. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancetii:407.","journal-title":"Lancet"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jcp.10053","volume":"190","year":"2002","unstructured":"Grant, C., K. Barmak, T. Alefantis, J. Yao, S. Jacobson, and B. Wigdahl. 2002. Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J. Cell. Physiol.190:133-159.","journal-title":"J. Cell. Physiol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1073\/pnas.95.13.7568","volume":"95","year":"1998","unstructured":"Greten, T. F., J. E. Slansky, R. Kubota, S. S. Soldan, E. M. Jaffee, T. P. Leist, D. M. Pardoll, S. Jacobson, and J. P. Schneck. 1998. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19-specific CD8+ T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM\/TSP patients. Proc. Natl. Acad. Sci. USA95:7568-7573.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0022-510X(94)90299-2","volume":"122","year":"1994","unstructured":"Ichinose, K., T. Nakamura, Y. Nishiura, K. Nagasato, K. Ohishi, H. Watanabe, A. Fujita, K. Kurouji, M. Tsujihata, and S. Nagataki. 1994. Characterization of adherent T cells to human endothelial cells in patients with HTLV-I-associated myelopathy. J. Neurol. Sci.122:204-209.","journal-title":"J. Neurol. Sci."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4049\/jimmunol.161.1.482","volume":"161","year":"1998","unstructured":"Kubota, R., T. Kawanishi, H. Matsubara, A. Manns, and S. Jacobson. 1998. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy\/tropical spastic paraparesis patients by intracellular cytokine detection. J. Immunol.161:482-488.","journal-title":"J. Immunol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0165-5728(99)00175-7","volume":"102","year":"2000","unstructured":"Kubota, R., T. Kawanishi, H. Matsubara, A. Manns, and S. Jacobson. 2000. HTLV-I specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals. J. Neuroimmunol.102:208-215.","journal-title":"J. Neuroimmunol."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/13550289709015802","volume":"3","year":"1997","unstructured":"Levin, M. C., and S. Jacobson. 1997. HTLV-I associated myelopathy\/tropical spastic paraparesis (HAM\/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. J. Neurovirol.3:126-140.","journal-title":"J. Neurovirol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0952-7915(02)00366-7","volume":"14","year":"2002","unstructured":"Lieberman, J., N. Manjunath, and P. Shankar. 2002. Avoiding the kiss of death: how HIV and other chronic viruses survive. Curr. Opin. Immunol.14:478-486.","journal-title":"Curr. Opin. Immunol."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00019052-200106000-00019","volume":"14","year":"2001","unstructured":"Nagai, M., and S. Jacobson. 2001. Immunopathogenesis of human T cell lymphotropic virus type I-associated myelopathy. Curr. Opin. Neurol.14:381-386.","journal-title":"Curr. Opin. Neurol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","year":"1998","unstructured":"Nagai, M., K. Usuku, W. Matsumoto, D. Kodama, N. Takenouchi, T. Moritoyo, S. Hashiguchi, M. Ichinose, C. R. Bangham, S. Izumo, and M. Osame. 1998. Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J. Neurovirol.4:586-593.","journal-title":"J. Neurovirol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/13550280260422668","volume":"8","year":"2002","unstructured":"Osame, M. 2002. Pathological mechanisms of human T-cell lymphotropic virus type-I-associated myelopathy (HAM\/TSP). J. Neurovirol.8:359-364.","journal-title":"J. Neurovirol."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","year":"1980","unstructured":"Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA77:7415-7419.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/300063a0","volume":"300","year":"1982","unstructured":"Popovic, M., M. S. Reitz, Jr., M. G. Sarngadharan, M. Robert-Guroff, V. S. Kalyanaraman, Y. Nakao, I. Miyoshi, J. Minowada, M. Yoshida, Y. Ito, and R. C. Gallo. 1982. The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group. Nature300:63-66.","journal-title":"Nature"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.13.6021-6030.2000"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1089\/08892220050193263","volume":"16","year":"2000","unstructured":"Sonoda, S., H. C. Li, L. Cartier, L. Nunez, and K. Tajima. 2000. Ancient HTLV type 1 provirus DNA of Andean mummy. AIDS Res. Hum. Retrovir.16:1753-1756.","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-510X(00)00322-1","volume":"177","year":"2000","unstructured":"Wu, X. M., M. Osoegawa, K. Yamasaki, Y. Kawano, H. Ochi, I. Horiuchi, M. Minohara, Y. Ohyagi, T. Yamada, and J. I. Kira. 2000. Flow cytometric differentiation of Asian and Western types of multiple sclerosis, HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) and hyperIgEaemic myelitis by analyses of memory CD4 positive T cell subsets and NK cells subsets. J. Neurol. Sci.177:24-31.","journal-title":"J. Neurol. Sci."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ana.410260304","volume":"26","year":"1989","unstructured":"Yoshida, S., M. Osame, H. Kawai, M. Toita, N. Kuwasaki, Y. Nishida, Y. Hiraki, K. Takahashi, K. Nomura, S. Sonoda, N. Eiraku, and K. Usuku. 1989. Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann. Neurol.26:331-335.","journal-title":"Ann. Neurol."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.11.6.1105-1110.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.11.6.1105-1110.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T04:48:03Z","timestamp":1682830083000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.11.6.1105-1110.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1128\/CDLI.11.6.1105-1110.2004"],"URL":"https:\/\/doi.org\/10.1128\/cdli.11.6.1105-1110.2004","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]},"assertion":[{"value":"2003-09-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-07-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}